Developing Cell Therapies Leveraging Automated Manufacturing to Reduce COGs while Maintaining Product Quality

• Discussing strategies to achieve the highest yield with automated manufacturing
• Exploring the stage of development at which to introduce automation
• Showcasing data achieved using automated manufacturing processes in CAR-T and CARNK therapies

Speakers:

Xiuyan Wang

Director - Cell Therapy & Cell Engineering Core

Memorial Sloan Kettering Cancer Center